메뉴 건너뛰기




Volumn 135, Issue 6, 2015, Pages 1-3

What is a pragmatic clinical trial?

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; CLINICAL TRIAL (TOPIC); DERMATOLOGY; ETHNIC GROUP; HEALTH CARE POLICY; HUMAN; PATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHORT SURVEY; COST BENEFIT ANALYSIS; METHODOLOGY; PEMPHIGOID, BULLOUS; TREATMENT OUTCOME; UNITED KINGDOM; UNITED STATES;

EID: 84938069361     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2015.134     Document Type: Article
Times cited : (47)

References (11)
  • 1
    • 84865337745 scopus 로고    scopus 로고
    • The value of the pragmatic-explanatory continuum indicator summary wheel in an ongoing study: The Bullous Pemphigoid Steroids and Tetracyclines Study
    • Bratton DJ, Nunn AJ, Wojnarowska F et al. (2012) The value of the pragmatic-explanatory continuum indicator summary wheel in an ongoing study: the Bullous Pemphigoid Steroids and Tetracyclines Study. Trials 13:50
    • (2012) Trials , vol.13 , pp. 50
    • Bratton, D.J.1    Nunn, A.J.2    Wojnarowska, F.3
  • 2
    • 84948709750 scopus 로고    scopus 로고
    • A randomised controlled trial to compare the safety and effectiveness of doxycycline (200 mg/day) with oral prednisolone (0.5 mg/kg/day) for initial treatment of bullous pemphigoid: A protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial
    • e-pub ahead of print 13 February 2015
    • Chalmers JR, Wojnarowska F, Kirtschig G et al. (2015) A randomised controlled trial to compare the safety and effectiveness of doxycycline (200 mg/day) with oral prednisolone (0.5 mg/kg/day) for initial treatment of bullous pemphigoid: a protocol for the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) Trial. Br J Dermatol; e-pub ahead of print 13 February 2015
    • (2015) Br J Dermatol
    • Chalmers, J.R.1    Wojnarowska, F.2    Kirtschig, G.3
  • 3
    • 84866391313 scopus 로고    scopus 로고
    • Anti-IL-17 receptor antibody AMG 827 leads to rapid clinical response in subjects with moderate to severe psoriasis: Results from a phase I, randomized, placebo-controlled trial
    • Papp KA, Reid C, Foley P et al. (2012) Anti-IL-17 receptor antibody AMG 827 leads to rapid clinical response in subjects with moderate to severe psoriasis: results from a phase I, randomized, placebo-controlled trial. J Invest Dermatol 132:2466-9
    • (2012) J Invest Dermatol , vol.132 , pp. 2466-2469
    • Papp, K.A.1    Reid, C.2    Foley, P.3
  • 4
    • 0032561868 scopus 로고    scopus 로고
    • What are pragmatic trials?
    • Roland M, Torgerson DJ (1998) What are pragmatic trials? BMJ 316:285
    • (1998) BMJ , vol.316 , pp. 285
    • Roland, M.1    Torgerson, D.J.2
  • 5
    • 68249103874 scopus 로고    scopus 로고
    • Comparative effectiveness research: A report from the Institute of Medicine
    • Sox HC, Greenfield S (2009) Comparative effectiveness research: a report from the Institute of Medicine. Ann Intern Med 151:203-5
    • (2009) Ann Intern Med , vol.151 , pp. 203-205
    • Sox, H.C.1    Greenfield, S.2
  • 6
    • 33748291419 scopus 로고    scopus 로고
    • Effectiveness and cost-effectiveness of salicylic acid and cryotherapy for cutaneous warts. An economic decision model
    • ix-87
    • Thomas KS, Keogh-Brown MK, Chalmers JR et al. (2006) Effectiveness and cost-effectiveness of salicylic acid and cryotherapy for cutaneous warts. An economic decision model. Health Technol Assess 10:iii, ix-87
    • (2006) Health Technol Assess , vol.10 , pp. iii
    • Thomas, K.S.1    Keogh-Brown, M.K.2    Chalmers, J.R.3
  • 7
    • 84877289504 scopus 로고    scopus 로고
    • Penicillin to prevent leg cellulitis recurrence
    • Thomas KS, Crook AM, Nunn AJ et al. (2013) Penicillin to prevent leg cellulitis recurrence. N Engl J Med 368:1695-703
    • (2013) N Engl J Med , vol.368 , pp. 1695-1703
    • Thomas, K.S.1    Crook, A.M.2    Nunn, A.J.3
  • 8
    • 63449090101 scopus 로고    scopus 로고
    • A pragmatic-explanatory continuum indicator summary (PRECIS): A tool to help trial designers
    • Thorpe KE, Zwarenstein M, Oxman AD et al. (2009) A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol 62:464-75
    • (2009) J Clin Epidemiol , vol.62 , pp. 464-475
    • Thorpe, K.E.1    Zwarenstein, M.2    Oxman, A.D.3
  • 9
    • 67649661825 scopus 로고    scopus 로고
    • Making trials matter: Pragmatic and explanatory trials and the problem of applicability
    • Treweek S, Zwarenstein M (2009) Making trials matter: pragmatic and explanatory trials and the problem of applicability. Trials 10:37
    • (2009) Trials , vol.10 , pp. 37
    • Treweek, S.1    Zwarenstein, M.2
  • 10
    • 84856865636 scopus 로고    scopus 로고
    • The growth of clinical trials and systematic reviews in informing dermatological patient care
    • Williams HC, Dellavalle RP (2012) The growth of clinical trials and systematic reviews in informing dermatological patient care. J Invest Dermatol 132:1008-17
    • (2012) J Invest Dermatol , vol.132 , pp. 1008-1017
    • Williams, H.C.1    Dellavalle, R.P.2
  • 11
    • 84925359642 scopus 로고    scopus 로고
    • Clinical trials submitted to the JID: Place your bet and show us your hand
    • Williams HC, Gilchrest B (2015) Clinical trials submitted to the JID: place your bet and show us your hand. J Invest Dermatol 135:325-7
    • (2015) J Invest Dermatol , vol.135 , pp. 325-327
    • Williams, H.C.1    Gilchrest, B.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.